QIAGEN powered by

QIAGEN OmicSoft OncoLand

Accelerate cancer research with an oncology database of curated cancer genomics data

QIAGEN OncoLand is an oncology database with integrated visualization software that helps cancer researchers easily explore high-quality public and private cancer genomics data and cancer datasets. Leverage QIAGEN’s world-class analysis pipelines, cancer dataset curation and data management tools to accelerate your oncology research projects – from cancer biomarker discovery, new target identification and target validation, to drug repositioning and indication discovery.

Fast, scalable cancer genomics data and analytics

Used in nearly all stages of drug development (from discovery to preclinical and clinical research), OncoLand oncology database encompasses multi-omics platforms, while providing a standardized pipeline for incorporation of data, with controlled vocabularies for associated information on cancer datasets. Every project is expertly curated using an extensive set of controlled vocabularies to make the data FAIR (findable, accessible, interoperable and reusable).

  • Broad support for genomic data types and hundreds of curated and quality-controlled public cancer genome datasets
  • Powerful visualization and analytics to compare and correlate within and across datasets
  • Internal “Land” next-generation database technology provides very fast access to a large number of genomic datasets

Focus on downstream research

No need to reinvent the wheel: QIAGEN’s bioinformatics team spends thousands of computing, curation and download hours each year to keep up with rapidly growing cancer genomics data so you don’t have to. By using our pre-curated cancer datasets and powerful analytics, you can:

  • Quickly identify high-quality, well-curated oncology datasets
  • Easily interrogate your data and our data with a visual Cancer Genomics Tool
  • Organize your oncology database for compliance with pharma industry data standards
  • Save valuable time and resources while empowering cancer biomarker research

“QIAGEN OmicSoft Lands save me a lot of time – rather than find, download, process and annotate individual data sets, I focus on testing hypotheses and exploring the data right away.”

-Dr. Arthur Liberzon, Bioinformatician, Alkermes, Inc.

Capabilities

Using QIAGEN OmicSoft OncoLand oncology database, the possibilities for biological discoveries from cancer datasets are endless:

  • Integrates the largest public consortium datasets, including TCGA, GTEx, Blueprint, CCLE, CGCI, ICGC, TARGET, TRACERx and more
  • Supports more than 20 major genomic data types and thousands of clinical measures
  • Analytics and visualizations of DNA-seq, RNA-seq, fusions, protein expression, copy number, methylation and clinical attributes
  • Securely integrate your internal cancer datasets with public data
  • Compare normal tissue expression to tumor and cell line data (e.g., GTEx vs TCGA vs CCLE)
  • Identify mutation patterns within and across diseases
  • Identify top gene fusions at nucleotide resolution
  • Correlate mutation and copy number variation with expression
  • Define custom cohorts to compare expression, copy number and more

Featured Resources

Infographic

Explore our powerful solutions for biomarker and target discovery

Brochure

Explore how QIAGEN OmicSoft OncoLand can help you dig deeper into your 'omics data to extract novel insights

Powerful cloud-enabled ‘omics GUI, complete NGS analysis workflows and unparalleled curated content for immediate exploration

Request a trial of QIAGEN OncoLand today